“WEBINAR” Vaccine Development Live influenza Virus Bioprocessing
We understand that one of today’s main vaccine challenges is the rapid production of effective and safe vaccines at a lower cost. Join Dr. Mats Lundgren and find out how innovative cell culture and purification process can help you address this challenge.
Vaccine Development Webinar—Live Influenza Virus Bioprocessing
Wednesday, 8 December 2010
07:00, 14:00 and 19:00 CET
8:00 AM and 1:00 PM EST
New Delhi: 11:30 IST
Beijing: 14:00 CST
Presented by Dr Mats Lundgren
Senior Scientist, GE Healthcare Life Sciences
During this webinar you will gain insights on how to:
| Speed up and optimize your vaccine development and manufacturing processes at a reduced production cost | |
| Implement flexible disposable manufacturing to easily respond to sudden demand for larger volume of vaccine doses | |
| Use label-free interaction data to ensure optimal efficacy and safety of released products | |
| Apply this generic process to different types of cell culture-based vaccines |
Register today and let us help you reach your goals in vaccine research and production!
Attend this webinar and receive two NEW brochures on our flexible, ready-to-use platform of solutions—ReadyToProcess™, and our label-free interaction analysis tools for vaccine design, development and production.
Related posts: